Search
for
Sort by
Research 721–750 of 1000+
- Testosterone therapy for transgender men
- Lichen Planopilaris: Update on Diagnosis and Treatment
- Estrogens and aging skin
- Hormone therapy for transgender patients
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Lupus erythematosus: systemic and cutaneous manifestations
- Hormone replacement therapy and the skin
- Estrogens and the skin
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- The Distribution of Estrogen Receptor β Is Distinct to That of Estrogen Receptor α and the Androgen Receptor in Human Skin and the Pilosebaceous Unit
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Obesity and the skin
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- The role of androgen and androgen receptor in skin-related disorders
- Histopathology of non-scarring alopecia
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- HAIR REGROWTH
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Cutaneous reactions to recombinant cytokine therapy
- Androgens and androgen receptor action in skin and hair follicles
- Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Dermatologic manifestations of endocrine disorders
- Learning from nudity: lessons from the nude phenotype
- Pharmacological Activity and Clinical Use of PDRN
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*